The CDC’s latest virus tracker data shows that respiratory illness activity has climbed to some of the highest levels seen ...
Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...
The state Department of Health is advising Rhode Islanders to get flu shots and take other preventive measures as the illness ...
Peak season ranges from late December to mid-February every year, the CDC website says. Last year in North Carolina, RSV ...
Federal health officials upended the immunization schedule for American children this week. These are the diseases affected.
Report Ocean’s comprehensive analysis delves into the Respiratory Syncytial Virus (RSV) landscape, encompassing historical data, forecasted epidemiology, and market trends globally. The report ...
Recently, Pfizer made public a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Subsequently, there has been an increased interest in developing RSV therapies ...